Literature DB >> 22805251

Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome.

Jay Desai1, Wendy G Mitchell.   

Abstract

Acute cerebellar ataxia and acute cerebellitis represent a process characterized by parainfectious, postinfectious, or postvaccination cerebellar inflammation. There is considerable overlap between these entities. The mildest cases of acute cerebellar ataxia represent a benign condition that is characterized by acute truncal and gait ataxia, variably with appendicular ataxia, nystagmus, dysarthria, and hypotonia. It occurs mostly in young children, presents abruptly, and recovers over weeks. Neuroimaging is normal. Severe cases of cerebellitis represent the other end of the spectrum, presenting with acute cerebellar signs often overshadowed by alteration of consciousness, focal neurological deficits, raised intracranial pressure, hydrocephalus, and even herniation. Neuroimaging is abnormal and the prognosis is less favorable than in acute cerebellar ataxia. Acute disseminated encephalomyelitis may be confused with acute cerebellitis when the clinical findings are predominantly cerebellar, but lesions on neuroimaging are usually widespread. Paraneoplastic opsoclonus-myoclonus syndrome is often initially misdiagnosed as acute cerebellar ataxia, but has very specific features, course, and etiopathogensis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22805251     DOI: 10.1177/0883073812450318

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  17 in total

1.  Reversible diffusion restriction of the middle cerebellar peduncles and dentate nucleus in acute respiratory syncytial virus cerebellitis: a case report.

Authors:  Y Tang; B Suddarth; X Du; J A Matsumoto
Journal:  Emerg Radiol       Date:  2013-09-07

2.  Magnetic resonance imaging findings in patients presenting with (sub)acute cerebellar ataxia.

Authors:  Tanja Schneider; Götz Thomalla; Einar Goebell; Anna Piotrowski; David Mark Yousem
Journal:  Neuroradiology       Date:  2015-02-17       Impact factor: 2.804

Review 3.  Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors:  Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

4.  Can MRI Differentiate between Infectious and Immune-Related Acute Cerebellitis? A Retrospective Imaging Study.

Authors:  G Orman; S F Kralik; N K Desai; A Meoded; H Sangi-Haghpeykar; G Jallo; E Boltshauser; T A G M Huisman
Journal:  AJNR Am J Neuroradiol       Date:  2021-09-30       Impact factor: 3.825

5.  Clinical Reasoning: An 8-Year-Old With Acute Onset Ataxia.

Authors:  John Robert McLaren; Matthew Kyler Mitchell; Fatima Mohamed Al-Maadid; Kevin Joseph Staley
Journal:  Neurology       Date:  2022-06-03       Impact factor: 11.800

6.  Distinct cerebellar regions related to motor and cognitive performance in SCA6 patients.

Authors:  Zubir Rentiya; Noore-Sabah Khan; Ezgi Ergun; Sarah H Ying; John E Desmond
Journal:  Neuropsychologia       Date:  2017-10-31       Impact factor: 3.139

7.  Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.

Authors:  Bilal Gani Taib; Andrew J Kinshuck; Philip Milburn-McNulty; Lauren Fratalia; Leigh Forsyth; David Husband; Terry M Jones; Anu Jacob
Journal:  J Med Case Rep       Date:  2015-06-02

8.  West nile virus encephalitis induced opsoclonus-myoclonus syndrome.

Authors:  Chad J Cooper; Sarmad Said
Journal:  Neurol Int       Date:  2014-04-22

9.  Acute post-infectious cerebellar ataxia due to co-infection of human herpesvirus-6 and adenovirus mimicking myositis.

Authors:  Aldo Naselli; Giovanna Pala; Federico Cresta; Martina Finetti; Roberta Biancheri; Salvatore Renna
Journal:  Ital J Pediatr       Date:  2014-11-26       Impact factor: 2.638

10.  Cerebellitis as a rare manifestation of scrub typhus fever.

Authors:  Samiksha Gupta; Sahil Grover; Monica Gupta; Daljinderjit Kaur
Journal:  BMJ Case Rep       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.